Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Investor

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (“Fosun Pharma”), a leading healthcare company in China,which was established in 1994, has been listed on Shanghai Stock Exchange since August 1998. Specializing in modern biopharmaceutical and healthcare industry, Fosun Pharma has captured opportunities within the rapidly developing Chinese healthcare industry as well as from the globalization of Chinese healthcare companies in general. Fosun Pharma's operations strategically cover several important segments of the healthcare industry value-chain, including: pharmaceutical manufacturing, distribution and retail. In particular, the Company has a leading market position and unmatched advantages in pharmaceutical distribution and retail, healthcare services, diagnostic products and medical devices, and maintains a strong focus on research and development, and manufacturing. As one of the largest healthcare companies in China, Fosun Pharma enjoys a competitive advantage in research and development, innovation, marketing, integration of mergers and acquisitions, as well as human resources. Fosun Pharma strongly believes in the principle of sustainable development and has incorporated social responsibility into its long-term business strategy. In full recognition of its social role, Fosun Pharma endeavors to meet the needs of its community, customers, employees and shareholders throughout conducting its business and its future development.

Invests into

Technology: N/A
Industry: Regenerative Medicine
Headquarters: Shanghai, China
Founded Date: 1994
Employees Number: 10001+
Funding Status: IPO
Investor Type: undisclosed
Investment Stage: Undisclosed
Number Of Exits: 2

Visit Website
Register and Claim Ownership